Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that persistent chemotherapy-induced alopecia in breast cancer patients frequently resembles androgenetic alopecia, and treatment with minoxidil, alone or with antiandrogens, improved hair density in many cases.

In this report, five female patients undergoing hormonal anticancer therapy for breast cancer prevention developed pattern alopecia, which the authors attribute to androgen-estrogen imbalance caused by antiestrogenic drugs.

In this study, synchrotron fibre diffraction identified changes in dermal collagen microfibrillar radius with age, with lower radii observed in individuals with insulin-dependent diabetes mellitus.

This review highlights the possible impact of side effects from endocrine therapy on quality of life, emphasizing that these can lead to poor adherence and early treatment discontinuation in patients with hormone receptor positive early breast cancer, potentially worsening survival outcomes.

In this study, researchers found that shorter CA repeats in the ERbeta gene are correlated with PSA expression, and PSA immunoexpression is associated with increased disease-free survival in breast cancer.

This study found that Sudanese breast cancer survivors receiving hormonal or HER2-targeted therapies had better quality of life compared to those on conventional therapy.

This study found that near-infrared microscopy can effectively detect complete medulla loss in scalp hair, which may serve as a potential biomarker for breast cancer diagnosis.

This study found that newly diagnosed breast cancer patients in Korea have different hair mineral patterns, notably reduced zinc levels, which negatively correlate with body mass index compared to normal controls.

The authors reported that electrochemotherapy and electroporation-based treatments, both with and without cytotoxic drugs, show promise as safer and more effective options for breast cancer treatment, including metastatic cases and palliative care, in vitro and in vivo.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

In this study, researchers examined skin growth and quality in Pekin ducks from 1 to 6 weeks of age, finding that skin factors like strength and collagen content increased with age and were influenced by gene expressions related to cell proliferation and collagen synthesis.

This study evaluated a new computer-aided detection system for identifying Breast Arterial Calcification in mammograms, achieving 70% accuracy, but highlighted the need for a larger dataset to explore its relationship with cardiovascular diseases.

This study found that although initiation of breastfeeding is common among mothers in Abha, Saudi Arabia, discontinuation before the recommended duration is prevalent, especially among those with higher education and employment.

This study concluded that oncoplastic breast surgery is a more cost-effective treatment than standard lumpectomy for large-breasted patients, despite higher initial costs.

This study reports that scalp cooling is 40%-90% effective in preventing chemotherapy-induced hair loss among breast cancer patients, particularly with taxane-based treatments, though some exhibited discontinuation due to mild side effects.

In this study involving South African breast cancer patients, researchers identified certain genetic variations in cytochrome P450 and other enzymes potentially linked to differences in tamoxifen treatment outcomes, suggesting a need for more comprehensive pharmacogenomic studies to optimize therapy in African populations.

This study reported that an Ayurveda-based regimen of Guduchi, Ashwagandha, and Curcumin may safely improve quality of life, including physical and emotional functioning, in breast cancer patients receiving conventional therapy, with no serious adverse events over an 8-week period.

This study found that 49% of female breast cancer patients treated with CDK4/6 inhibitors for at least three months developed alopecia, which significantly impacted their quality of life, with greater alopecia severity leading to worse emotional and functional well-being.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

This review highlights the potential of herbal remedies as complementary options for breast cancer care, noting benefits like immune modulation and reduced chemotherapy side effects, in contrast to conventional treatments that often cause significant side effects and long-term health issues.

This study observed that female breast cancer patients receiving chemotherapy most commonly reported "worrying" as a psychological symptom and "weight loss" as a physical symptom, while coping strategies included praying or meditating for active coping, and using distractions like movies and shopping for passive coping.

This case report describes a woman who experienced worsened breast implant illness symptoms following a COVID-19 infection and vaccination, which improved after implant removal, even though numerous screenings had been inconclusive prior to explantation.

This letter highlights the lack of evidence on managing persistent alopecia induced by chemotherapy and endocrine therapy in breast cancer patients, noting that prior studies have not included endocrine therapy-induced alopecia.

This study identified specific genes involved in radiation-induced fibrosis in skin, capsule, and muscle tissues of breast cancer patients, offering insights that may help improve mitigation strategies for these side effects.

This study found that the computer-controlled RV-01 scalp cooling device helped prevent significant hair loss in metastatic breast cancer patients treated with eribulin, with none of the 16 patients requiring a wig and experiencing minimal discomfort.

Nephronectin is linked to worse outcomes in breast cancer and helps cancer spread.

This retrospective study observed that breast cancer treatments disrupted normal blood counts and led to bone marrow suppression, highlighting the need for nutritional counseling to improve patient quality of life.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.